Great analysis. One point worth adding, is that no one produces a product overnight. It's a 3-5 year process after registration with the TGA and starting with a drug candidate. Auscann have never registered a product with the TGA (this is the public domain) and they have not declared any drug candidates. So it does appear to be newsflow to elevate the stock price. I think "Paper Tiger" is very polite - it's more an invisible tiger.
AC8 Price at posting:
45.0¢ Sentiment: Sell Disclosure: Not Held